Updated 2026-09-08 · NCT07165028See eligibility →
Treatment
Retatrutide clinical trials
Active studies that list Retatrutide as an intervention or treatment.
10active studies
1recruiting now
13countries represented
743largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Updated 2026-08-24 · NCT06383390See eligibility →
Active, not recruitingPhase 3
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
Updated 2026-07-23 · NCT07035093See eligibility →
Updated 2026-07-20 · NCT06297603See eligibility →
Active, not recruitingPhase 3
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Updated 2026-07-20 · NCT06662383See eligibility →
Updated 2026-07-16 · NCT06982859See eligibility →
Active, not recruitingPhase 3
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight
Updated 2026-06-09 · NCT07357415See eligibility →
Active, not recruitingPhase 3
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
Updated 2026-04-17 · NCT07232719See eligibility →
Updated 2026-04-13 · NCT06260722See eligibility →
Active, not recruitingPhase 3
A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity
Updated 2026-03-03 · NCT06859268See eligibility →
Related treatments
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.